Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 7.2% in the afternoon session after the company reported a solid second-quarter earn...
Health insurance company Humana (NYSE:HUM) announced better-than-expected revenue in Q2 CY2026, with sales up 26.2% year on year to $40.87 billion. Its non-G...
Humana Inc. (NYSE: HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately.
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2026 (2Q26) versus the quarter ended June 30, 2025 (2Q25) and for the six months ended June 30, 2026 (YTD 2026) versus the six months ended June 30, 2025 (YTD 2025) as noted in the tables below.
A new study from Humana Healthcare Research (HHR), published in Health Affairs Scholar, finds that favorable selection in Medicare Advantage (MA) may be significantly lower than commonly cited estimates suggest. Favorable selection refers to the extent to which MA enrollees incur lower costs than predicted after risk adjustment and is an important factor in MA payment policy debates. The study found that a single methodological refinement substantially reduced favorable selection estimates compared with previous analyses by MedPAC and others.
Health insurance company Humana (NYSE:HUM) will be announcing earnings results this Wednesday before the bell. Here’s what you need to know. Humana met analy...
Investor litigation firm Kaskela Law announces that it is investigating Humana Inc. (NYSE: HUM) (“Humana”) on behalf of the company’s long-term investors.
Healthcare Services Group (NASDAQ:HCSG) reported second-quarter 2026 revenue of $470.8 million, with management citing disciplined execution, steady industry fundamentals and continued demand for outsourced services in long-term and post-acute care.
Chief Executive Officer Ted Wahl said the company
PLANO, Texas - Custom Health Plans, a licensed health insurance brokerage based in Plano, is marking more than three decades of helping Texans compare and enroll in health coverage. The milestone comes as Texas continues to face the highest uninsured rate in the United States.
The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advanceme...
As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:H...
Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.
